GSK’s shares fell sharply following a judge's decision to allow more than 70,000 lawsuits to proceed, alleging it’s Zantac ...
GSK shares have plunged after a ruling by a Delaware judge that will force the company to face trial by jury for its Zantac ...
Shares in British drugmaker GSK fell sharply Monday following a Delaware judge's decision to allow more than 70,000 lawsuits to ... to testify that Zantac may cause cancer. GSK, along with former ...
Zantac hit the US market as a prescription drug in 1983 before transforming into an over-the-counter heartburn treatment in ...
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
Pfizer Inc (NYSE:PFE) released longer-term follow-up results from the Phase 3 CROWN trial evaluating Lorbrena (lorlatinib) ...